Date Filed | Type | Description |
01/11/2023 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.
Txns:
| Granted 20,000 shares
@ $0 |
|
06/24/2022 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $0.7132, valued at
$17.8k
|
|
01/12/2022 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns:
| Granted 65,430 shares
@ $0 |
|
06/21/2021 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $4.04, valued at
$80.8k
|
|
01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/14/2020 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns:
| Granted 18,292 restricted stock units
@ $3.28, valued at
$60k
|
|
12/05/2019 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CAMBREX CORP
Txns:
| Sold 9,015 shares
@ $60, valued at
$540.9k
Exercised 360 options to buy
@ $44.225, valued at
$15.9k
Exercised 1,980 options to buy
@ $53.7, valued at
$106.3k
Exercised 2,766 options to buy
@ $40.06, valued at
$110.8k
|
|
06/17/2019 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns:
| Granted 13,350 options to buy
@ $4.38, valued at
$58.5k
|
|
04/25/2019 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CAMBREX CORP
Txns:
| Granted 2,247 shares
@ $0 Granted 2,766 options to buy
@ $40.06, valued at
$110.8k
|
|
01/16/2019 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns:
| Granted 12,121 restricted stock units
@ $4.95, valued at
$60k
|
|
01/10/2019 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns:
| Granted 8,747 shares
@ $0 |
|
07/26/2018 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns:
| Granted 26,700 options to buy
@ $15, valued at
$400.5k
|
|
07/24/2018 |
3
| BROWN GREGORY B (Director) has filed a Form 3 on Aquestive Therapeutics, Inc. |
04/30/2018 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CAMBREX CORP
Txns:
| Granted 1,397 shares
@ $0 Granted 1,980 options to buy
@ $53.7, valued at
$106.3k
|
|
01/10/2018 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns:
| Granted 8,747 restricted stock units
@ $0 |
|
11/02/2017 |
4
| BROWN GREGORY B (Director) has filed a Form 4 on CAMBREX CORP
Txns:
| Granted 265 shares
@ $0 Granted 360 options to buy
@ $44.225, valued at
$15.9k
|
|
11/02/2017 |
3
| BROWN GREGORY B (Director) has filed a Form 3 on CAMBREX CORP |
05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |